Aurinia Pharmaceuticals reports financial results for the three and nine months ended September 30, 2026

AUPH•2026-10-30

Aurinia Pharmaceuticals reported financial results for the three and nine months ended September 30, 2026, and provided an update on recent business progress.

Aurinia Pharmaceuticals reports financial results for the three and nine months ended September 30, 2026

1. Financial results

Related News

Gorilla Technology issues warrant to purchase up to 850,612 ordinary shares

Femasys appoints John Moorhead to board of directors

Benchmark Treasury yield retreat puts key trend support in focus

Viatris commences tender offer to acquire Pacira BioSciences

Howmet Aerospace: JPMorgan cuts target price to $285 from $350